Drugs

Drugmakers win battle in Third Circuit Court of Appeals over Health Resources and Services Administration, as courts decided HRSA went beyond the law with regulatory overreach.

The FDA said Thursday that there are still too many unknowns about the burgeoning market for CBD products to regulate them as either food or supplements.

Juul is looking for a new backer as FDA order banning its vaporette remains in limbo pending trial. Talks have included Philip Morris, Japan Tobacco Group, and Altria.

The company continues to see pressure on sales from staffing shortages at hospitals, which have limited growth in procedures using J&J products, while inflation has boosted expenses.

Lilly said it would work with the FDA to evaluate the fastest pathway to get its Alzheimer’s drug to market after what it believes was a successful trial.

Oklahoma announced new settlements totaling $226.1 million with three pharmacy chains and a drug manufacturer over the opioid epidemic on Wednesday.

New York's first legal recreational marijuana dispensary, Housing Works Cannabis Co, opened in Lower Manhattan on Thursday, with dozens of others on the way.

Boston area company Viken Detection is providing Customs and Border Protection under-vehicle scanners at dozens of points of entry along the U.S. southern border.

FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.

The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.

Long lines have formed outside of Portland, Oregon's Shroom House, as patrons wait to buy psilocybin. Recreational psychedelic mushroom sales are still illegal, however.

Walmart is the latest company to announce a settlement with local governments over allegations of improperly filling prescriptions for powerful painkillers

CVS Health has announced a $5 billion deal that, if approved, would make it the first major pharmacy chain to reach a nationwide settlement of opioid lawsuits.

The FDA-recalled quinapril and hydrochlorothiazide tablets were shipped to customers nationwide in May 2021. No related adverse reactions have been reported.

Amylyx says doctors will be able to prescribe Relyvrio immediately. The drugmaker anticipates prescriptions will be filled and shipped from specialty pharmacies within the next four to six weeks.

A study found that Biogen's Alzheimer's drug lecanemab reduced cognitive and functional decline by 27% compared to a placebo over an 18-month period.

Biogen is accused of causing submissions of false claims to Medicare and Medicaid by paying physicians kickbacks to prescribe its multiple sclerosis drugs Avonex, Tysabri and Tecfidera.

PharmaTech's previous co-owner, Raidel Figueroa, has been sentenced to over three years for lying to the FDA and allowing contaminated medicine to go to pediatric hospitals.

New Hampshire Attorney General John Formella announced that the state reached a $40.5 million settlement with Johnson & Johnson over opioid claims on Thursday.